HPA Antibodies and the Distribution of Antigen and Antibodies
Multi-center Study in the Frequency of HPA Antibodies and the Distribution of Antigen and Antibodies in Chinese Blood Disease Patients
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Listed as NCT03408158, this NA trial focuses on Antibody-mediated Rejection and Blood Disease and remains completed. Sponsored by First Affiliated Hospital Xi'an Jiaotong University, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2023 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Sep 2021 [monthly]
Unknown Status NA
▶ Show 4 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Feb 2019 — Jan 2020 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital Xi'an Jiaotong University
- First Affiliated Hospital of Harbin Medical University
- Guangzhou First People's Hospital
- Hunan Provincial People's Hospital
- LanZhou University
- Nanfang Hospital, Southern Medical University
- Sun Yat-sen University
- The Fourth Affiliated Hospital of China Medical University
- The Third Affiliated Hospital of Guangzhou Medical University
For direct contact, visit the study record on ClinicalTrials.gov .